![Pierandrea Muglia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pierandrea Muglia
Technik-/Wissenschafts-/F&E-Leiter bei
SANA AB
Vermögen: 428 580 $ am 31.05.2026
Profil
Pierandrea Muglia was the founder of GRIN Therapeutics, Inc., founded in 2021, and served as President from 2021 to 2022.
The current jobs include Chief Executive Officer at Ichnos SRL and Chief Medical Officer at Saniona AB starting in 2025.
Former jobs include Vice President & Head-Experimental Medicine at NTG Nordic Transport Group A, Chief Marketing Officer at Handl Therapeutics BV, and Vice President at UCB Pharma SA (Belgium) from 2012 to 2019.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SANIONA AB 0,19 % | 31.12.2024 | 259.999 ( 0,19 % ) | 428 580 $ | 31.05.2026 |
Aktive Positionen von Pierandrea Muglia
| Unternehmen | Position | Beginn |
|---|---|---|
| SANA AB | Technik-/Wissenschafts-/F&E-Leiter | 10.03.2025 |
Ehemalige bekannte Positionen von Pierandrea Muglia
| Unternehmen | Position | Ende |
|---|---|---|
GRIN Therapeutics, Inc.
 GRIN Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of precision therapeutics for pediatric neurodevelopmental disorders | Gründer | 01.09.2022 |
UCB Pharma SA (Belgium)
 UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | 01.10.2019 |
Handl Therapeutics BV
 Handl Therapeutics BV BiotechnologyHealth Technology Provides gene therapy treatment solutions | Vertrieb & Marketing | - |
| NTG NORDIC TRANSPORT GROUP A/S | Direktor/Vorstandsmitglied | 28.05.2010 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
NTG Nordic Transport Group A/S
 NTG Nordic Transport Group A/S TruckingTransportation Transports goods through truck, ship and aircraft | Transportation |
UCB Pharma SA (Belgium)
UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Saniona AB
 Saniona AB BiotechnologyHealth Technology Engages in the research and development of drugs to treat the central nervous system diseases | Health Technology |
Handl Therapeutics BV
Handl Therapeutics BV BiotechnologyHealth Technology Provides gene therapy treatment solutions | Health Technology |
GRIN Therapeutics, Inc.
GRIN Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of precision therapeutics for pediatric neurodevelopmental disorders | Commercial Services |
